Navigation Links
Marijuana-Derived Drug Promises Hope In Treating Bladder Infection

Interstitial cystitis is primarily a disease of middle-aged women and is characterized by recurring discomfort or pain in the bladder and surrounding pelvic region. Symptoms vary and can include a combination of mild to severe pain, pressure and tenderness in the bladder and pelvic area; and an urgent and/or frequent need to urinate. // Additionally, the bladder wall may become scarred or irritated, and pinpoint bleeding may appear on the bladder wall.

There appears to be no definitive treatment for interstitial cystitis. The therapy usually employed frequently affords partial relief, but it may be completely ineffective.

"Interstitial cystitis is a difficult disease to treat, and not all treatments work well on all patients," said Michael Chancellor, M.D., professor of urology at the University of Pittsburgh School of Medicine. "Any new option we can give our patients to alleviate their painful symptoms is very exciting."

General treatment involves the prescription of sedatives but seldom afford relief. Associated urinary infection is treated with appropriate antibiotics. Most patients respond to the conservative management. Persistent symptoms may require surgical intervention.

IP 751, the principal active ingredient of marijuana has been found to effectively suppress pain and bladder over activity in hypersensitive bladder disorders such as interstitial cystitis (IC). However, the study has been conducted only on animal models.

IP 751 is a potent anti-inflammatory and a powerful analgesic, although the mechanisms by which it works are unknown.

IP 751 was injected into rat models of acute and subacute bladder inflammation. IP 751 significantly suppressed bladder over activity in both animal models without affecting bladder contractility. By stopping the underlying cause of irritation - over activity of the bladder - IP 751 is able to eliminate the associated pain.

Perhaps more randomized trials in human beings could offer a new hope for the disease in the future.


'"/>




Related medicine news :

1. Bladder Pain Suppressed By Marijuana-Derived Drug
2. LINK Applied Genomics Programme Promises To Revolutionize Healthcare Systems
3. Diarrhea Vaccine Trials Promises Prevention of Rotavirus Infection
4. Maternal Vitamin D Supplementation Promises Healthy Bones In Child
5. Raw Vegan Diet Promises Lightweight, Healthy Bones
6. Stem Cell Transplantation Promises Cure for Type 2 Diabetes
7. New Drug Promises Hope In Multiple Drug Resistant And Latent TB Treatment
8. Health Minister Promises Strict Quality Control On Herbal Medicines
9. Anti-Cancer Treatment Promises Hope in Bird Flu Treatment
10. Nanotechnology Promises Huge Medical Benefits
11. Health Minister Promises New Benchmark for Wait Times
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/18/2017)... ... 2017 , ... At Hallmark Nameplate, their commitment to quality is what sets ... ISO 13485. This certification is another way they are making constant strides to provide ... they need. , The ISO 13485 Certification is a major accomplishment for Hallmark Nameplate ...
(Date:1/18/2017)... ... January 18, 2017 , ... Michael ... new website for its Center for Biosimilars, announced Michael J. Hennessy Associates, Inc. ... in the field of biosimilars through thought leader interaction in, live video and ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... problems ranging from gum disease to enamel erosion, and those dental problems can ... Department of Public Health, many pregnant women are failing to get the dental ...
(Date:1/17/2017)... ... January 17, 2017 , ... Anesthesia Progress – Everyone ... choose the best drug option for each patient. Dentists have several general anesthesia alternatives ... outcomes. , Researchers from the Tokyo Dental College in Tokyo, Japan wanted to find ...
(Date:1/17/2017)... ... January 17, 2017 , ... For breast cancer clinicians and researchers ... those who desire a more intimate review and analysis of its highlights, a novel ... Bedside—is being offered by Imedex on February 4, 2017 in Chicago. Chaired by Kathy ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... 2017   Spotlight Innovation Inc. (OTCQB: ... in the second quarter of 2017, to launch ... to provide relief from chronic pain, is a ... was developed under a licensing agreement with Dr. ... from snake venom. Additionally, Caretta Therapeutics has signed ...
(Date:1/18/2017)... , Jan 18, 2017 Research and Markets ... Vomiting Drugs Market 2017-2021" report to their offering. ... The global CINV drugs ... 2017-2021. Global Thoracic Surgery Market 2017-2021, has been ... experts. The report covers the market landscape and its growth prospects ...
(Date:1/18/2017)... -- In China , we say Health ... of China,s Healthy Strategy originates. 2016 ... Economic and Social Development of the People,s Republic ... state council of the People,s Republic of China ... development plan, identifying medical devices as one of the main ...
Breaking Medicine Technology: